4.5 Article

The Non-hormonal Male Contraceptive Adjudin Exerts its Effects via MAPs and Signaling Proteins mTORC1/rpS6 and FAK-Y407

Journal

ENDOCRINOLOGY
Volume 162, Issue 1, Pages -

Publisher

ENDOCRINE SOC
DOI: 10.1210/endocr/bqaa196

Keywords

MAP; microtubule; testis; spermatogenesis; Sertoli cells; adjudin; cadmium chloride

Funding

  1. Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD056034]
  2. National Key Research and Development Program of China [2018YFC1003500]
  3. National Natural Science Foundation of China (NSFC) [81730042]
  4. China Shenzhen Science Technology and Innovative Commission (SZSTI) [SZSTI-JCYJ20180508152336419]
  5. China Pharmaceutical University World Explorer Study Abroad Scholarship

Ask authors/readers for more resources

Adjudin is a nonhormonal male contraceptive that induces reversible male infertility without perturbing hormone levels. It works by disrupting specific junctions in the testis to induce spermatid exfoliation, without affecting germ cell development. Studies suggest that its contraceptive effects are mediated through changes in microtubule associated proteins and signaling proteins.
Adjudin, 1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide (formerly called AF-2364), is a nonhormonal male contraceptive, since it effectively induces reversible male infertility without perturbing the serum concentrations of follicle stimulating hormone (FSH), testosterone, and inhibin B based on studies in rats and rabbits. Adjudin was shown to exert its effects preferentially by perturbing the testis-specific actin-rich adherens junction (AJ) at the Sertoli-spermatid interface known as apical ectoplasmic specialization (apical ES), thereby effectively inducing spermatid exfoliation. Adjudin did not perturb germ cell development nor germ cell function. Also, it had no effects on Sertoli cell-cell AJ called basal ectoplasmic specialization (basal ES), which, together with tight junction constitute the blood-testis barrier (BTB), unless an acute dose of adjudin was used. Adjudin also did not perturb the population of spermatogonial stem cells nor Sertoli cells in the testis. However, the downstream signaling protein(s) utilized by adjudin to induce transient male infertility remains unexplored. Herein, using adult rats treated with adjudin and monitored changes in the phenotypes across the seminiferous epithelium between 6 and 96 h in parallel with the steady-state protein levels of an array of signaling and cytoskeletal regulatory proteins, recently shown to be involved in apical ES, basal ES and BTB function. It was shown that adjudin exerts its contraceptive effects through changes in microtubule associated proteins (MAPs) and signaling proteins mTORC1/rpS6 and p-FAK-Y407. These findings are important to not only study adjudin-mediated male infertility but also the biology of spermatogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available